Indications for the use of Fansidar in malaria.
D000962:Antimalarials / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004348:Drug Labeling; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D011739:Pyrimethamine / Q000627:therapeutic use*; D013413:Sulfadoxine / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine